Expertise in
1
conditions

Ian S. Dayes

1280 Main Street West, 
Hamilton, ON, CA 
Expertise in
1
conditions
1280 Main Street West, 
Hamilton, ON, CA 

Overview

Ian Dayes practices practicing medicine in Hamilton, Canada.

Mr. Dayes is highly rated in 1 condition, according to our data. His clinical expertise encompasses Prostate Cancer, Breast Cancer, Proctitis, HER-2 Positive Breast Cancer, and Prostatectomy.

He is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

1280 Main Street West, Hamilton, ON L8S4L8, Canada
Other Locations
Hamilton, Canada
Vancouver, BC, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
View 1 Less Clinical Trial

52 Total Publications

Editorial expression of concern: Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.
Editorial expression of concern: Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.
Journal: Radiation oncology (London, England)
Published: July 06, 2026

Frequently Asked Questions about Ian S. Dayes

Is Ian S. Dayes a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ian S. Dayes is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ian S. Dayes participate in research or clinical trials?

Yes. Ian S. Dayes has published 52 articles and abstracts on conditions like Prostate Cancer. You can view a list of Ian S. Dayes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dayes's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile